KLK3 and Familial prostate cancer: Gallium 68 PSMA-11 has recently received FDA approval for use in the United States for PET imaging of PSMA positive lesions in patients with suspected prostate cancer metastasis as well as patients with suspected prostate cancer recurrence based on elevated PSA levels.